Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Evidence

PTSD and trauma symptoms

LAST REVIEWED 2026-05-18 · 346 SOURCES · 0 CORRECTIONS

PTSD-related signals often appear within veteran or substance-use populations rather than standalone PTSD trials.

Confidence: ModerateSource type: Study
Evidence level
secondary outcomes and observational
Sample sizes
Currently tied mainly to small observational cohorts and secondary analyses.
Design quality
Controlled studies with clear PTSD endpoints and adequate follow-up remain limited.
Outcomes
PTSD symptom scales, sleep, functioning, substance use, depression, and narrative meaning are not the same outcome.
Limitations
Confounding, expectation effects, integration/support differences, psychiatric exclusions, and concurrent interventions.
Safety signals
Psychiatric destabilization, suicidality screening, medications, acute monitoring, and post-session support.
What is not proven
Ibogaine is not proven as a PTSD treatment.
Best next source
Veteran TBI studies and updated psychiatric scoping reviews.